PPARα antagonist inhibited RCC and NHK cell viability.

<p>RCC cells (Caki-1 and 786-O) were treated with DMSO, WY14,643 (WY), or GW6471 (GW) at the indicated doses from 12.5 to 100 µM for 72 hours and a cell viability assay was performed as described in Materials & Methods. The data shown are representative of at least three repeats. *p<0.05 compared to DMSO. Error bars indicate standard deviation.